Inventor · disambiguated record
Samuel Chackalamannil
Also filed as: CHACKALAMANNIL SAMUEL
77 granted patents·17 pending applications·1,682 citations·filing 1986–2014
99Inventor score
Files withSCHERING CORP57NEELAMKAVIL SANTHOSH FRANCIS6BOYLE CRAIG D5MERCK SHARP & DOHME5CHACKALAMANNIL SAMUEL3
Top patents by PatentIndex Score
94 records- 0198US6821978B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2001·Granted Nov 23, 2004·140 cites·34 claims
- 0298US5883096AMuscarinic antagonistsSCHERING CORP·Filed 1996·Granted Mar 16, 1999·164 cites·17 claims
- 0397US6326380B1Thrombin receptor antagonistsSCHERING CORP·Filed 2000·Granted Dec 4, 2001·103 cites·10 claims
- 0497US6063847AThrombin receptor antagonistsSCHERING CORP·Filed 1998·Granted May 16, 2000·180 cites·18 claims
- 0596US6645987B2Nor-seco himbacine derivatives useful as thrombin receptor antagonistsSCHERING CORP·Filed 2001·Granted Nov 11, 2003·97 cites·14 claims
- 0696US6037352AMuscarinic antagonistsSCHERING CORP·Filed 1998·Granted Mar 14, 2000·90 cites·11 claims
- 0796US5977138AEther muscarinic antagonistsSCHERING CORP·Filed 1997·Granted Nov 2, 1999·99 cites·19 claims
- 0895US5939419A2-benzyl-polycyclic guanine derivatives and process for preparing themSCHERING PLOUGH CORP·Filed 1994·Granted Aug 17, 1999·83 cites·9 claims
- 0994US6630475B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2001·Granted Oct 7, 2003·53 cites·17 claims
- 1093US5889006AMuscarinic antagonistsSCHERING CORP·Filed 1996·Granted Mar 30, 1999·123 cites·18 claims
- 1192US7304078B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted Dec 4, 2007·43 cites·67 claims
- 1292US7037920B2Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonistsSCHERING CORP·Filed 2002·Granted May 2, 2006·52 cites·15 claims
- 1392US6969719B2Polycyclic guanine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2002·Granted Nov 29, 2005·59 cites·26 claims
- 1491US7776889B2Spirocyclic thrombin receptor antagonistsSCHERING CORP·Filed 2006·Granted Aug 17, 2010·20 cites·8 claims
- 1590US8907095B2Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119XIA YAN·Filed 2008·Granted Dec 9, 2014·23 cites·14 claims
- 1690US6288068B1Muscarinic antagonistsSCHERING CORP·Filed 2000·Granted Sep 11, 2001·22 cites·5 claims
- 1788US6894065B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted May 17, 2005·31 cites·16 claims
- 1887US6897217B22-Alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2004·Granted May 24, 2005·25 cites·21 claims
- 1986US7713999B2Thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted May 11, 2010·8 cites·46 claims
- 2085US8278334B2Cyclic amine BACE-1 inhibitors having a benzamide substituentCUMMING JARED N·Filed 2009·Granted Oct 2, 2012·7 cites·10 claims
- 2184US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 2284US7572802B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineSCHERING CORP·Filed 2006·Granted Aug 11, 2009·7 cites·15 claims
- 2384US5608067A4-substituted pyrazoloquinoline derivativesFiled 1994·Granted Mar 4, 1997·25 cites·4 claims
- 2483US8815876B2Bicyclic heterocycle derivatives and methods of use thereofNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Granted Aug 26, 2014·7 cites·16 claims
- 2582US8003803B2Fused ring thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted Aug 23, 2011·4 cites·4 claims
- 2682US6916811B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2002·Granted Jul 12, 2005·17 cites·9 claims
- 2782US6043255AMuscarinic antagonistsSCHERING CORP·Filed 1999·Granted Mar 28, 2000·50 cites·16 claims
- 2881US9328138B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted May 3, 2016·8 cites·17 claims
- 2981US8022088B2Substituted bicyclic and tricyclic thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted Sep 20, 2011·5 cites·10 claims
- 3081US7713985B2Adenosine Aa2 receptor antagonistsSCHERING CORP·Filed 2007·Granted May 11, 2010·4 cites·13 claims
- 3181US7531544B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2007·Granted May 12, 2009·2 cites·3 claims
- 3280US7888369B2Oxazoloisoquinoline derivatives as thrombin receptor antagonistsSCHERING CORP·Filed 2006·Granted Feb 15, 2011·4 cites·8 claims
- 3380US7662816B2Cyclic amine BACE-1 inhibitors having a benzamide substituentSCHERING CORP·Filed 2004·Granted Feb 16, 2010·11 cites·25 claims
- 3480US7488752B2Thrombin receptor antagonistsSCHERING CORP·Filed 2005·Granted Feb 10, 2009·6 cites·25 claims
- 3580US7368449B22-alkynyl- and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted May 6, 2008·4 cites·16 claims
- 3679US7442712B2Constrained himbacine analogs as thrombin receptor antagonistsSCHERING CORP·Filed 2005·Granted Oct 28, 2008·6 cites·15 claims
- 3778US7465740B22-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2006·Granted Dec 16, 2008·3 cites·17 claims
- 3876US8318751B2Pyrimidinone derivatives and methods of use thereofBOYLE CRAIG D·Filed 2008·Granted Nov 27, 2012·3 cites·42 claims
- 3976US6890936B2Muscarinic antagonistsSCHERING CORP·Filed 2003·Granted May 10, 2005·9 cites·26 claims
- 4075US8389532B27-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amineBOYLE CRAIG D·Filed 2009·Granted Mar 5, 2013·2 cites·4 claims
- 4174US7709492B2Pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted May 4, 2010·2 cites·20 claims
- 4274US7488742B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted Feb 10, 2009·5 cites·15 claims
- 4374US6897216B2Adenosine A2a receptor antagonistsSCHERING CORP·Filed 2003·Granted May 24, 2005·5 cites·6 claims
- 4474US6498168B2Muscarinic antagonistsSCHERING CORP·Filed 2001·Granted Dec 24, 2002·5 cites·5 claims
- 4572US9062007B2Cyclic amide BACE-1 inhibitors having a benzamide substituentPHARMACOPEIA DRUG DISCOVERY·Filed 2014·Granted Jun 23, 2015·1 cites·6 claims
- 4672USRE44205EAdenosine A2a receptor antagonistsNEUSTADT BERNARD R·Filed 2012·Granted May 7, 2013·2 cites·21 claims
- 4772US7741318B2Pyrazolo [1,5-A]pyrimidine adenosine A2a receptor antagonistsSCHERING CORP·Filed 2005·Granted Jun 22, 2010·2 cites·20 claims
- 4872US7268141B2Xanthine phosphodiesterase V inhibitorsSCHERING CORP·Filed 2004·Granted Sep 11, 2007·4 cites·22 claims
- 4971US8822480B2Bicyclic heterocycle derivatives and use thereof as GPR119 modulatorsNEELAMKAVIL SANTHOSH FRANCIS·Filed 2009·Granted Sep 2, 2014·1 cites·19 claims
- 5071US5476847ADerivatives of phosphinic acid useful as endothelin converting enzyme inhibitorsSCHERING CORP·Filed 1994·Granted Dec 19, 1995·25 cites·29 claims
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Samuel Chackalamannil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →